News | November 11, 2013

Biotronik Receives CE Mark for PK Papyrus Covered Coronary Stent for Perforations

PK Papyrus may provide greater flexibility and reduced crossing profile compared to competition

stents cath lab biotronik pk papyrus
November 11, 2013 — Biotronik announced that the PK Papyrus covered coronary stent system has received CE mark for the treatment of acute coronary artery perforation.
 
According to Biotronik, PK Papyrus boasts 58 percent greater flexibility than Abbott's Jostent Graftmaster due to its "electrospun" membrane. The enhanced electrospinning technology allows for a proprietary single-layer covered stent design rather than the traditional "sandwich technique" used on comparable stents on the market. The single-layer covered stent design, with its 90 ?m polyurethane membrane, further enables a 24 percent lower crossing profile in comparison to Abbott's Jostent Graftmaster, combining high flexibility and a low crossing profile for exceptional deliverability while sealing vessel defects in acute situations.
 
Many current covered stent designs require large French size guide catheters. Switching guide cathethers can cost the physician valuable time, delaying treatments. PK Papyrus is 5 and 6 French compatible, thereby eliminating the need to switch access catheters during these emergency situations.
 
"In acute situations when there is a vessel perforation, I need a stent that is highly effective and has optimum deliverability,” said Georg Nickenig, M.D., Ph.D., professor and chief, Department of Cardiology, University Hospital Bonn in Bonn, Germany. “With PK Papyrus, I am confident that, if such a situation arises, I have a stent that is straight-forward to introduce into the artery with a flexibility that means simplified placement."
 
While PK Papyrus is based on the same proven Orsiro/PRO-Kinetic Energy stent platform, the wide size range (diameter: 2.5-5 mm, length: 15-26 mm) enables a broad range of vessels to be treated confidently and efficiently.
 
For more information: www.biotronik.com

Related Content

Tryton Side Branch Stent Recognized With Premier Technology Breakthrough Award
News | Stents Bifurcation| September 21, 2017
September 21, 2017 — Cardinal Health and Tryton Medical Inc.
DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Overlay Init